Outlier test for reference replicate crossover study design [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2019-08-13 17:28 (1504 d 23:20 ago) – Posting: # 20495
Views: 1,846

Hi Abhimanyu,

❝ I have question regarding outlier test (Using Lund's method) for reference replicate crossover study design.


Sounds like a bad idea.

❝ How can we find outlier? which one will be appropriate scenario for any regulatory point of view?


The trick is to avoid generating outliers. In my small universe, there is no problem that merits a solution involving identification and and removal of outliers.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,761 posts in 4,775 threads, 1,628 registered users;
23 visitors (0 registered, 23 guests [including 14 identified bots]).
Forum time: 16:48 CEST (Europe/Vienna)

Whenever a theory appears to you as the only possible one,
take this as a sign that you have neither understood the theory
nor the problem which it was intended to solve.    Karl R. Popper

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5